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Abstract
Background: In the fish liver, the synthesis of egg yolk protein precursor vitellogenin (VTG) is under control of the
estrogen receptor alpha (ERα). Environmental contaminants such as 2,3,7,8-tetrachloro-dibenzo-p-dioxin (TCDD) are
suspected to have antiestrogenic effects. The aryl hydrocarbon receptor (AHR) is the initial cellular target for TCDD
and related compounds. The AHR is a ligand-activated transcription factor that stimulates the expression of the genes
encoding xenobiotic metabolizing enzymes, such as cytochrome P450 1A (CYP1A). In this study, the effects of activation
of AHR on the hepatic expression of VTG and ERα genes, in primary cultured salmon hepatocytes, have been
investigated.
Results: The expression of the genes encoding VTG and ERα were strongly induced by 17β-estradiol (E2). However,
the expression of VTG was disrupted by exposure of the cells to TCDD while CYP1A expression was enhanced. The
effect of TCDD on VTG and CYP1A expression was annulled by the AHR-inhibitor α-naphthoflavone. Furthermore,
exposure of the cells to TCDD abolished E2-induced accumulation of ERα mRNA. The AHR-mediated inhibitory effects
on the expression of the VTG and ERα genes may occur at transcriptional and/or post-transcriptional levels. Nuclear
run-off experiments revealed that simultaneous exposure of the cells to E2 and TCDD strongly inhibited the initiation
of transcription of the VTG and ERα genes. In addition, inhibition of RNA synthesis by actinomycin D treatment showed
that post-transcriptional levels of VTG and ERα mRNAs were not significantly altered upon treatment of the cells with
TCDD. These results suggested that activation of AHR may inhibit the transactivation capacity of the ERα. Further,
electrophoretic mobility shift assays using nuclear extracts prepared from cells treated for one or two hours with E2,
alone or in mixture with TCDD, showed a strong reduction in the DNA binding activities upon TCDD treatment. These
results also suggested that activation of the AHR signalling pathway caused a marked decrease in the number of the
nuclear ERα or that activated AHR blocked the ability of ERα to bind to its target DNA sequence. Finally, our results
from Northern hybridizations indicated that E2 treatment of the cells did not cause any significant effect on the TCDD-
induced levels of CYP1A mRNA.
Conclusion: In fish hepatocytes E2 induces ERα and VTG gene expression. The presence of dioxin (TCDD) abolishes
this induction, probably through the action of AHR in complex with AHR nuclear translocator, and possibly by direct
interference with the auto-regulatory transcriptional loop of ERα. Furthermore, E2 does not interfere with TCDD
induced CYP1A gene expression, suggesting that cross-talk between the ERα- and AHR-signalling pathways is
unidirectional.
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Background
The liver is a central organ for sexual reproduction and
development of the embryo in oviparous vertebrates. In
teleost fish, much of the yolk is synthesized by liver cells
in the form of a protein precursor: the vitellogenin (VTG).
VTG is a large phosphoglycolipoprotein which is synthe-
sized in the liver under hormonal control and secreted
into the bloodstream [1,2]. The VTG is incorporated into
the developing oocyte by receptor-mediated endocytosis
[3,4] and processed into three smaller proteins: phosvitin,
a phosphorus containing protein, and two lipid contain-
ing proteins, lipovitellins I and II [5-7]. These become the
primary substances stored as yolk. In the female fish, the
induction of VTG synthesis (vitellogenesis) is under con-
trol of the hepatic estrogen receptor α (ERα). The induc-
tion of vitellogenesis is triggered by environmental cues
and is regulated by coordinated endocrine feedback loops
between the hypothalamus, pituitary, gonad and liver
(HPGL axis) [1]. Briefly, environmental signals induce the
hypothalamus to release gonadotropin releasing hor-
mones which stimulate the release of gonadotropins from
the pituitary. The gonadotropin hormones, in turn, stim-
ulate the follicle cells to synthesize 17β-estradiol (E2). The
estradiol is released into the blood and transported into
the liver where it enters the hepatocytes by diffusion and
binds with high affinity to the ERα. The activated ERα trig-
gers the expression of its own gene and subsequently that
of the VTG.
Polycyclic aromatic hydrocarbons (PAHs) and polyhalo-
genated aromatic hydrocarbons (PHAHs) are suspected to
have deleterious effects on fish vitellogenesis [8]. A
number of these compounds including polychlorinated
dibenzo-p-dioxins such as 2,3,7,8-tetrachlorodibenzo-
para-dioxin (TCDD) exert their effects through the aryl
hydrocarbon receptor (AHR). The AHR is a ligand-acti-
vated transcription factor that regulates the activation of
several genes that encode phase I and phase II drug metab-
olism enzymes in the liver (reviewed in ref. [9]). The AHR
belongs to the family of basic helix-loop-helix (bHLH)/
Per-Arnt-Sim (PAS) proteins which are characterized by
two conserved domains, the N-terminal bHLH and the
PAS domain (reviewed in ref. [10]).
The cytochrome P4501A (CYP1A) is an enzyme involved
in the metabolism of many drugs and xenobiotics which
is regulated by the AHR. The molecular mechanism
involved in the activation of the CYP1A have been exten-
sively studied [11]. Prior to binding of the ligand the
cytosolic form of the AHR is associated with a chaperon-
ing complex consisting of heat shock protein 90 (HSP90)
and several other co-chaperones [10]. Upon binding of
the ligand, the AHR is released from the HSP90 complex
and translocated into the nucleus where it dimerizes with
a structurally related protein, the Ah Receptor Nuclear
Translocator (ARNT). The AHR/ARNT complex binds
with high affinity to specific DNA sequences termed
dioxin response elements (DREs) located in the regulatory
regions of the target genes leading to activation of their
expression.
TCDD has been shown to inhibit several estrogen-
induced responses in the rodent uterus, mammary gland
and in the mammalian cell cultures (reviewed in [12,13]).
The cross-talk between the ERα and AHR signalling path-
way has not been extensively studied in the fish. However,
recent studies using fish primary cultures of hepatocytes
showed that AHR-ligands have an inhibitory effect on the
estrogen-induced synthesis of VTG [14,15]. On the other
hand, conflicting findings were observed in in vivo expo-
sures of fish to xenoestrogens and Ah-receptor ligands
[16].
The efforts of this study have been concentrated on the
mechanism behind cross-talk between the AHR- and ERα-
signalling pathways in the fish liver. Our results show that
activation of the AHR pathway has contradictory effects
on the molecular functions of the ERα in the liver cells.
Activation of the AHR inhibits the ERα to initiate tran-
scription of the VTG gene and blocks the auto-regulatory
loop of the ERα gene expression. The cross-talk between
the two receptors, however, appears to be unidirectional,
i.e., activation of the ERα has no significant inhibitory
effect on the AHR-mediated induction of the CYP1A.
Results
Effects of TCDD, β-naphthoflavone, and α-
naphthoflavone on E2-induced vitellogenin gene 
expression
The expression of VTG gene in the fish liver is positively
regulated by 17β-estradiol (E2). The first step in our stud-
ies was to examine how exposure of the liver cells to
TCDD alters the E2-induced VTG gene expression. The
primary cultured fish hepatocytes were exposed to a con-
stant concentration of E2 and/or E2 combined with
increasing concentrations of TCDD. As shown in Figure 1,
exposure of the cells to 10 nM E2 resulted in a strong
induction of the VTG gene expression. Exposure of the
cells to a combination of E2 and TCDD, however, resulted
in a strong reduction of VTG mRNA levels. The inhibitory
effect of TCDD on the VTG gene expression was compara-
ble to the negative effects of tamoxifen. Tamoxifen is able
to interfere with binding of estrogen to its receptor and to
prevent activation of the target genes by the receptor.
Interestingly, the negative effects of TCDD on the VTG
gene expression was diminished by the AHR antagonist α-
NF, indicating that the antiestrogenic effects of TCDD was
mediated through its interaction with the aryl hydrocar-
bon receptor. However, α-NF alone had no significant
effect on the E2-induced expression of VTG gene (FigureComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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2). To examine the capability of the AHR ligands to block
expression of VTG gene at the high estradiol concentra-
tions that may be reached during vitellogenesis [17], the
dose of E2 was raised 10 times compared to the previous
experiments. As shown in Figure 3a, TCDD showed simi-
lar inhibitory effects on the accumulation of VTG mRNA
levels even when the cells were exposed to such high con-
centration of E2 (100 nM). Additional experimental evi-
dence for involvement of AHR in this process was
obtained by performing assays using combinations of
estradiol with the AHR-ligand β-naphthoflavone (β-NF).
β-NF is a weaker ligand of the AHR and its potency as an
inducer of CYP1A protein and as an inhibitor of vitello-
genesis is lower than TCDD [14]. Nevertheless, β-NF
proved antiestrogenic at a concentration of 10 µM. Inter-
estingly, α-NF was capable to invert the negative effects of
β-NF on the expression of VTG gene at such low concen-
tration as 1 nM (Figure 3b).
Down-regulation of the estradiol-induced ERα gene 
expression by TCDD
The expression of the ERα in the liver cells is auto-regu-
lated. Therefore the antiestrogenic effects of TCDD might
be mediated through inhibitory mechanisms influencing
transcription of the ERα gene itself. This would result in
decreased number of the activated receptor and thus
reduced transcriptional activity of the VTG in response to
estradiol. In order to investigate the effects of TCDD on
The inhibitory effects of TCDD on the vitellogenin mRNA  levels Figure 1
The inhibitory effects of TCDD on the vitellogenin 
mRNA levels. After 48 hrs of culture the fish hepatocytes 
were left untreated or were treated with a fixed concentra-
tion of 17β-estradiol (E2) or E2 and increasing concentra-
tions of TCDD. Following a 12-h treatment period, total 
cellular RNA was isolated. Total RNA (20 µg per lane) was 
electrophoresed through a formaldehyde-containing agarose 
gel, transferred to a nylon membrane and sequentially 
hybridized to [α-32P]dCTP labelled cDNAs specific for VTG 
(VTG) and cytochrome P4501A (CYP1A). The top panel (A) 
shows the VTG gene expression, the panel in the middle (B) 
shows the expression of the CYP1A gene and bottom panel 
(C) displays the ethidium bromide staining of the gel to dem-
onstrate equal loading of the samples. The arrows indicate 
the position of 28S and 18S ribosomal RNAs. The numbers 
correspond to the kind of treatment of each sample as fol-
lows: #1: Control sample (cells treated with DMSO); #2: 
Cells treated with 10 nM E2; #3: Cells treated with E2 + 1 
pM TCDD; #4: Cells treated with E2 + 10 pM TCDD; #5: 
Cells treated with E2 + 100 pM TCDD; #6: Cells treated 
with E2 + 1 nM TCDD; #7: Cells treated with E2 + 10 nM 
TCDD; #8: Cells treated with E2 + 10 nM TCDD + 1 µM α-
NF; #9: Cells treated with E2 + 1 µM tamoxifen.
The effects of α-naphthoflavone on the E2-induced vitello- genin mRNA levels Figure 2
The effects of α-naphthoflavone on the E2-induced 
vitellogenin mRNA levels. The cultured fish hepatocytes 
were treated with 10 nM E2 or E2 plus increasing concentra-
tions of α-naphthoflavone (α-NF) (0–1 µM) for12 hrs. Total 
cellular RNA was subsequently isolated and 7.5 µg per sam-
ple was analyzed by slot blot hybridization. The membrane 
was hybridized with a [α-32P]dCTP labelled cDNA probe 
specific for VTG. The upper panel shows a representative 
slot blot membrane. The lower panel shows quantified radio-
activity using phosphoimager as photo stimulated luminis-
cence (PSL). The PSL values of three independent 
experiments and their means are shown in the plot diagram.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
Page 4 of 14
(page number not for citation purposes)
A) The negative effects of TCDD on the highly-induced vitellogenin gene expression Figure 3
A) The negative effects of TCDD on the highly-induced vitellogenin gene expression. The salmon hepatocytes 
were treated with 100 nM E2 or E2 and increasing concentrations of TCDD (1–10 nM). Following a 12-h treatment period, 
total cellular RNA was isolated and the expression of the VTG gene was assessed by Northern blot analysis as described (Fig-
ure 1). The upper panel shows the expression of the VTG gene while the lower panel displays the ethidium bromide staining of 
the gel to demonstrate equal loading of the samples. The arrows indicate the position of 28S and 18S ribosomal RNAs. B) 
Effects of α-NF on the antiestrogenic activity of β-NF Slot blot hybridization analysis of VTG gene expression in cul-
tured hepatocytes after treatment for 12 hrs with solvent (Control), fixed concentration of 17 β-estradiol (E2) (100 nM), E2 
plus α-naphthoflavone (α-NF) (1 µM) or E2 plus increasing concentrations of α-naphthoflavone (from 1 to 103 nM). Total RNA 
(5 µg) was applied per slot and hybridized with a [α-32P]dCTP labelled VTG cDNA probe. Radioactivity in each slot was quan-
tified using phosphoimager as photo stimulated luminiscence (PSL). The PSL values of three independent experiments and their 
means are shown in the plot diagram. Asterisk indicates significant difference (P < 0.05) with respect to the E2-treated sample 
(Dunnett's test).Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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the expression of the ERα gene, the cells were exposed to
a constant concentration of E2 and increasing concentra-
tions of TCDD and the variations in the VTG and ERα
mRNA levels were investigated. The results showed that
exposure of the cells to TCDD markedly reduced the
expression of both VTG and ERα genes (Figure 4). The
expression of these genes was strongly inhibited by the
two highest concentrations of TCDD (5 and 10 nM). A
positive correlation between the patterns of down-regula-
tion of the VTG and ERα genes indicated strongly that the
expressions of these genes were inhibited by a similar
mechanism.
Effects of TCDD on the transcription initiation and 
turnover rates of vitellogenin and estrogen receptor 
mRNAs
The AHR-mediated down-regulation of estrogen receptor
and VTG gene expression may occur at transcriptional
and/or post-transcriptional levels. In order to determine
the respective contributions of each mechanism, two
series of experiments were performed. In the first experi-
ment, the ability of the activated AHR to influence the ini-
tiation rate of VTG and ERα gene expressions was
investigated. The cells were either left untreated or treated
with E2 or E2 plus TCDD. After 8 hours the nuclei were
isolated and incubated with [α-32P]UTP. During the
period of incubation the radioactive label was incorpo-
rated into the nascent RNA chains which have been tran-
scribing when the nuclei were isolated resulting in
radioactive labelling of the activated genes. Our results
showed that the transcriptional activities of the ERα and
VTG genes strongly increased by E2 treatment, whereas
TCDD treatment mediated a strong reduction in the tran-
scriptional activities of these genes. At the same time, the
transcriptional activity of the CYP1A1 gene was markedly
increased suggesting that the inhibitory effects were medi-
ated through activation of the AHR (Figure 5).
In the second experiment, expression of the ERα and VTG
genes were induced by exposing the cells to E2 for 24
hours. At this point, the mRNA levels of the respective
genes have reached their maxima. The synthesis of the cel-
lular RNA was then blocked by exposing the cells to the
transcription-inhibitor actinomycin D while the cells were
either left untreated or exposed to 10 nM TCDD for a fur-
ther period of 24 hrs. The cells were harvested at various
time intervals and total cellular RNA from each sample
was prepared and analyzed by slot blot hybridization
using cDNA probes specific for ERα and VTG. The results,
however, showed no significant differences in the VTG
and ERα mRNA levels upon the treatment with TCDD
(Figures 6a and 6b, respectively). These results indicated
that activation of the AHR had no significant effect on the
post-transcriptional levels of the VTG and ERα mRNAs.
Effects of TCDD on the DNA binding activities of the 
nuclear extracts
The results obtained from nuclear run-off experiments
indicated strongly that activation of the AHR signalling
pathway may interfere with the ERα auto-regulatory loop
which might be caused by a significant decrease in the
number of activated ERα in the nucleus. We investigated
this possibility by performing an electrophoretic mobility
shift assay. Nuclear extracts were prepared from the cells
which were either left untreated or treated with E2 or E2
combined with increasing concentrations of TCDD. The
DNA binding activities present in the nuclear extracts were
detected using a biotin-labelled ERE oligonucleotide as
probe. As indicated in Figure 7, E2 treatment of the cells
increased formation of the ERα/ERE complex. The specif-
icity of DNA binding was verified by incubation of the
extract with a 100 times molar excess of the unlabelled
ERE probe which resulted in significant weakening of the
retarded band. Interestingly, the specific binding activity
of the nuclear extracts prepared from the cells simultane-
ously treated with E2 and TCDD was markedly weakened.
Reciprocal inhibitory effects of TCDD and E2 on the 
induction of vitellogenin and cytochrome P4501A1 gene 
expression
When establishing the inhibitory effects of the AHR-lig-
ands on the expression of the genes under control of the
ERα, it was interesting to investigate whether estrogen
exerts control over expression of the CYP1A, i.e., whether
the cross-talk between the two signalling pathways was
bidirectional. We performed assays where the cells were
exposed to 10 nM TCDD or TCDD combined with
increasing concentrations of E2. The results depicted in
Figure 8 show that activation of ERα by E2 had no pro-
nounced effect on the TCDD-stimulated levels of the
CYP1A mRNA. The CYP1A mRNA levels appeared con-
stant upon co-treatment with TCDD, E2 and ERα-inhibi-
tor tamoxifen (Figure 8, lanes 8 and 9). However,
treatment of the cells with TCDD plus testosterone did
not affect induction of the CYP1A gene (Figure 8, lane 7).
Discussion
In the present work, the effects of TCDD on the estrogen-
regulated gene expression in fish liver cells have been
investigated. The results showed that TCDD can oppose
E2-induced expression of the VTG gene in a concentra-
tion-dependent manner and exhibit a pronounced anti-
estrogenic effect at higher doses. The inhibitory effects of
TCDD on the E2-induced ERα signalling pathway were
comparable to the effects of tamoxifen. The latter is an
antagonistic ligand of ERα by competing with E2 in bind-
ing to the receptor and convert the receptor into an inacti-
vated form [18]. Our results, however, indicate that the
mechanism behind the anti-estrogenic action of TCDD is
completely different from those of tamoxifen and similarComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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TCDD- mediated down-regulation of vitellogenin and estrogen receptor α mRNAs Figure 4
TCDD- mediated down-regulation of vitellogenin and estrogen receptor α mRNAs. Slot blot hybridization analysis 
of hepatic VTG (A) and estrogen receptor alpha (B) after treatment with 17 β-estradiol (E2) and increasing concentrations of 
TCDD. After 48 hrs of culture, the cells were co-treated with a constant concentration of E2 (10 nM) and increasing concen-
trations of TCDD for 12 hrs. Total RNA (7.5 µg) was applied per slot and sequentially hybridized with [α-32P]dCTP labelled 
cDNA probes specific for VTG and ERα. Radioactivity in each slot was quantified using phosphoimager as photo stimulated 
luminiscence (PSL). The cells were treated as follows: Control: Cells treated with dimethylsulfoxid (DMSO) only. E2: Cells 
treated with 10 nM E2 for 12 hrs. Lane 3 – 7 labelled 0.1, 0.5, 1, 5, and 10: Cells co-treated with 10 nM E2 and increasing con-
centrations of TCDD (0.1, 0.5, 1, 5, and 10 nM, respectively) for 12 hrs. The PSL values of three independent experiments and 
their means are shown in the plot diagram. Asterisk indicates significant difference (P < 0.05) with respect to the E2-treated 
sample (Dunnett's test).
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classes of anti-estrogens. Our studies provide several lines
of evidence to establish the role of the AhR in mediating
the anti-estrogenic effects of TCDD: The Northern hybrid-
izations depicted in Figure 1 show that there is a clear neg-
ative relationship between the concentration-dependent
induction of the CYP1A1 gene and inhibition of the E2-
induced VTG gene expression. Other in vitro studies, using
primary cultured rainbow trout hepatocytes, showed that
the potency of the different classes of the AHR-ligands to
inhibit the VTG synthesis was directly related to their
capability to induce CYP1A1 protein levels and enzymatic
activities [14,15]. In addition, our results show that the
AHR antagonist, α-NF, is capable of markedly inversing
the inhibitory effects of the AHR ligands, TCDD and β-NF,
on the E2-triggered expression of the VTG gene. These
results supports previously reported studies using rat
hepatoma cells [19] and rainbow trout hepatocytes [15].
Activation of AHR by TCDD resulted in a marked reduc-
tion of ERα mRNA levels. These results are interesting
since ERα is the key regulator of the VTG gene expression.
In vertebrate oviparous species the expression of ERα in
the liver is induced by E2 [20-23]. Regulation of the ER
gene expression is an important aspect of the vitellogene-
sis, since the sensitivity of the target gene is directly
dependent on the cellular concentration of ER, i.e., the
estrogen receptor number is a rate-limiting factor in the
expression of the VTG gene [22]. There are several reports
suggesting that the AHR-ligands exert their inhibitory
effects on ER signalling by decreasing the levels of ER; for
example, treatment of mice with TCDD induced a
decrease in hepatic levels of ER mRNA levels [24]. Recent
studies using human breast cancer cell line T47D showed
that activation of the AHR by TCDD caused a specific pro-
teasome-dependent degradation of ERα [25,26]. Never-
theless, the inhibitory effects of TCDD on the ERα gene
expression appear to be cell-type specific. For example,
treatment of the human breast cancer cell line MCF-7 with
TCDD did not have any influence on the ERα mRNA lev-
els while it significantly down-regulated the expression of
the cathepsin D gene which is under the control of ERα
[27]. In another report, the effect of TCDD on the expres-
sion of a reporter gene under the control of the Xenopus
vitellogenin A2 regulatory sequences was studied. The
study revealed that TCDD could prevent reporter-gene
expression also when the cells transiently overexpressed
ER. These results suggested that the mechanism did not
involve downregulation of the ER by TCDD [28].
The negative effects of TCDD on the expression of ERα
and VTG genes, as indicated by decreasing of the levels of
their respective mRNAs, might be exerted at transcrip-
tional or post-transcriptional stages. Our results indicate
strongly that these effects are mediated through a mecha-
nism which blocks the activation of those genes.
The nuclear run-off transcription assays showed that E2
treatment induced the transcriptional activities of the ERα
and VTG genes while TCDD-treatment had a marked
inhibitory effect on the activation of these genes. One
important issue to be considered here is that the expres-
sion of the ERα and VTG genes in the fish liver are differ-
entially regulated [23,29]. The nuclear run-off
transcription studies showed that the expression of the
ERα gene reaches a plateau in about 10–12 hours while
the expression of the VTG gene continues to increase dur-
ing the 24 hours after the E2 treatment. These results sug-
gest that the auto-regulation loop of the ERα provides a
quick response to estrogen stimuli and subsequently trig-
gers the activation of the VTG gene. In this way, the ERα
provides the proper hepatic function necessary to meet
the challenging period of vitellogenesis. Our results,
however, suggest that despite their different transcrip-
tional rates, the activities of the ERα and VTG genes are
both significantly down-regulated by TCDD.
Effects of TCDD on the transcription rate of vitellogenin,  estrogen receptor α and cytochrome P4501A mRNAs Figure 5
Effects of TCDD on the transcription rate of vitello-
genin, estrogen receptor α and cytochrome P4501A 
mRNAs. Nuclear run-off experiments using primary cul-
tured hepatocytes treated with E2 (10 nM) or E2 (10 nM) 
plus TCDD (10 nM) for 8 hours. The cells were harvested 
and the activated nuclei were prepared. The [α-32P]UTP 
incorporated total RNA was prepared by in vitro transcrip-
tion assay as described in the methods. The radioactive 
labelled RNA samples were hybridized to the specific cDNAs 
for vitellogenin (VTG), estrogen receptor alpha (ERα) and 
cytochrome P4501A (CYP1A) cross-linked to the nylon 
membranes. Non-specific hybridization is indicated by 
hybridization of the labelled RNA with cloning plasmid 
pGEM-3Zf. The results shown are from a representative 
experiment repeated three times.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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The effects of TCDD on the stability of vitellogenin (VTG) and estrogen receptor α (ERα) mRNAs Figure 6
The effects of TCDD on the stability of vitellogenin (VTG) and estrogen receptor α (ERα) mRNAs. Primary cul-
tured hepatocytes were treated with E2 (10 nM) for 24 hours. The synthesis of RNA was then inhibited using actinomycin D 
(0.5 mg/ml medium). The cells were incubated for 0 to 24 hours in the presence or absence of TCDD (10 nM). The total RNA 
was then prepared from samples and 7.5 µg per slot of each sample was applied to nylon membranes. The membranes were 
sequentially hybridized with the [α-32P]dCTP labelled ERα and VTG probes. Radioactivity in each slot was quantified using 
phosphoimager as photo stimulated luminescence (PSL). The PSL values of two independent experiments are shown as mean ± 
2SD in the plot diagram.
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TCDD-mediated repression of DNA binding by ERα Figure 7
TCDD-mediated repression of DNA binding by ERα. Nuclear extracts prepared from primary hepatocytes, untreated 
or treated with estradiol (E2) or estradiol plus TCDD were used in the electrophoretic mobility shift assay. The oligonucle-
otide probe used contained the ERE (the underlined sequence) found in the 5'-regulatory region of the Atlantic salmon ERα 
gene (5'-TGTCATGTTGACC-3'). A) 3'-end biotin-labelled probe was mixed with nuclear extracts prepared from cells treated 
for 2 hrs as described below. The position of the retarded band (B) and the free probe (F) are indicated. Lane 1: Biotin-labelled 
ERE probe. Lane 2: nuclear extract from control cells (receiving DMSO only). Lane 3: cells treated with 10 nM E2. Lane 4: 10 
nM E2 with 100 X excess of unlabelled-ERE probe. Lane 5: 10 nM E2 and 1 nM TCDD. Lane 6: 10 nM E2 and 5 nM TCDD. 
Lane 7: nuclear extracts from cells treated with 10 nM E2 and 10 nM TCDD. B) Radio labelled ERE-probe was mixed with 
nuclear extract from cells treated for 1 hour and analyzed 6% non-denaturating polyacrylamide gel electrophoresis as follows: 
Lane 1: free ERE probe; Lane 2: cells treated with 0.1 nM E2; Lane 3: cells treated with 5 nM E2; Lane 4: cells treated with 10 
nM E2; Lanes 6–9: competition assays using nuclear extracts prepared from the cells treated with 10 nM E2 and receiving 100 
X excess of cold Oct-1 probe (Lane 6), 10 X excess of cold ERE probe (Lane 7), 50 X excess of cold ERE probe (Lane 8) or 
100 X excess of cold ERE probe (Lane 9). C) EMSA using radio labelled ERE-probe and nuclear extract from primary hepato-
cytes treated for 1 hour. Lane 1: free ERE probe. Lane 2: cells treated with 1 nM E2. Lane 3: extract from cells treated with 1 
nM E2 and binding reaction supplemented with 100 fold excess cold ERE probe (100 X). Lane 4: cells treated with 5 nM E2. 
Lane 5: sample as Lane 4, with 100 X cold ERE probe. Lane 6: cells treated with 10 nM E2. Lane 7: sample as Lane 6 with 100 X 
cold ERE. Lane 8: cells treated with 10 nM E2 and 1 nM TCDD. Lane 9: cells treated with 10 nM E2 and 5 nM TCDD. Lane 10: 
cells treated with 10 nM E2 and 10 nM TCDD.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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Post-transcriptional events including degradation and/or
stabilization of mRNA species are important mechanisms
for gene expression. Flouriot and co-workers showed that,
in fish liver, the E2-mediated induction of VTG mRNA
was brought about by an increase in the rate of VTG gene
transcription and by stabilization of cytoplasmic VTG
mRNA [23]. Further, these studies indicated that the proc-
ess of ERα mRNA stabilization was dependent on the
presence of an uncharacterized E2-induced protein factor.
In general, the stability of the mRNA has been determined
by site-specific mRNA endonucleases. Endonuclease-cata-
lyzed mRNA decay is regulated by RNA-binding proteins
which specifically bind to the target mRNAs and block
their cleavage by endonucleases (reviewed in [30]). For
example, stability of the hepatic VTG mRNA in Xenopus
laevis is regulated by an E2-induced RNA-binding protein,
vigilin, which binds specifically to a segment of the 3'-
UTR of the VTG mRNA and protects it from degradation
[31-33]. The results depicted in Figure 4 showed that treat-
ment of hepatocytes with 10 nM TCDD caused a signifi-
cant reduction the VTG and ERα mRNA levels. Therefore,
we performed an assay to investigate whether activation of
AHR could increase the turnover rate of VTG and ERα
mRNAs, i.e., whether activation of the AHR signalling
pathway would trigger any VTG and/or ERα specific
mRNA endonuclease activity. As the results presented in
Figure 6 show, exposure of the cells to TCDD had no
significant effect on the destabilization of VTG and ERα
mRNAs.
Electrophoretic mobility shift assays showed that the
nuclear extracts prepared from hepatocytes treated with
E2 specifically bound to the ERE, i.e., the nuclei were
enriched in the activated estrogen receptor. On the other
hand, the DNA binding activity of the nuclear extracts
from cells co-treated with estradiol and TCDD was mark-
edly decreased. The nature of this pronounced reduction
remains unknown. Nonetheless, our results indicate that
TCDD treatment may cause a marked depletion of the
nuclear ERα. Recently, Wormke et al. suggested a mecha-
nism for the inhibitory AHR-ERα cross-talk in breast can-
cer cells [26]. These authors showed that ligand activated
AHR recruits both ERα and proteasomes which results in
the degradation of both AHR and ERα. Due to lack of spe-
cific antibodies raised against salmon ERα protein, we
were not able to examine this mechanism in the salmon
liver cells.
Another interesting issue is whether cross-talk between
the two receptors is bidirectional. A bidirectional inhibi-
tory mechanism could arise from competition between
the two receptors for a common co-activator. For instance,
squelching of the nuclear factor-1 has been described
[34]; in addition, it has been shown that both AHR/ARNT
complex [35] and ERα are able to interact with general
transcription factor Sp1 [36,37]. Our experimental data
indicate that squelching would not primarily account for
cross-talk between the AHR- and ERα-signalling path-
ways, as E2 did not exert any inhibitory effect on the
expression of the CYP1A gene (Figure 8). These results
confirm data from experiments using primary cultured
rainbow trout hepatocytes [38]. However, Ricci et al. [34]
using several E2-sensitive human cells lines showed that
E2 treatment decreased the TCDD-induced CYP1A1
mRNA levels and transcriptional activities. A similar effect
has been reported in the human breast cancer cell line,
MCF-7 [27]; however, conflicting results has also
appeared [39]. Thus, the mutual interactions between the
ERα- and AHR-mediated signalling pathways appears to
be cell-type specific and to be regulated by specific protein
factors (co-activators or co-repressors) restricted to each
cell type. In our own laboratory, in vivo experiments with
The effects of E2 on the TCDD-stimulated expression of the  cytochrome P4501A (CYP1A) gene Figure 8
The effects of E2 on the TCDD-stimulated expres-
sion of the cytochrome P4501A (CYP1A) gene. After 
48 hrs of culture the fish hepatocytes were left untreated or 
were treated with a fixed concentration of TCDD or TCDD 
plus increasing concentration of E2. Following a 12-h treat-
ment period, total cellular RNA was isolated. Total RNA (20 
µg per lane) was electrophoresed through a formaldehyde-
containing agarose gel, transferred to a nylon membrane and 
sequentially hybridized to [α-32P]dCTP labelled cDNAs spe-
cific for cytochrome P4501A (CYP1A) and β-actin. The 
results shown are from a representative experiment 
repeated three times. The numbers correspond to treat-
ments as follows: #1: Control sample (cells treated with 
DMSO); #2: Cells treated with 10 nM TCDD; #3, 4, 5 and 6: 
Cells treated with 10 nM TCDD plus increasing concentra-
tions of E2 (0.1, 1, 10 and 100 nM respectively); #7: Cells 
treated with 10 nM TCDD+ 1 µM testosterone; #8: Cells 
treated with 10 nM TCDD + 10 nM E2 + 1 µM tamoxifen; 
#9: Cells treated with 10 nM TCDD + 100 nM E2 + 1 µM 
tamoxifen; #10: Cells treated with 10 nM TCDD + 1 µM 
tamoxifen.Comparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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salmon have indicated that AHR agonists, such as PCB-77,
can act both antagonistic and synergistic to xenoestrogen
(nonylphenol) stimulation on vitellogenesis and zona-
genesis, whereas no effect of the xenoestrogen was
observed on CYP1A levels [2,16]. Nevertheless, we have
also observed that prolonged treatment with high doses of
E2 or nonylphenol will provoke reduced CYP1A mRNA
levels in the liver of juvenile Atlantic salmon [40]. Activa-
tion of the mammalian ER-signalling pathway by the
AHR/ARNT complex or ARNT alone has been described
recently [41,42]. It has been shown that upon ligand
binding and nuclear translocation the AHR heterodimer-
ize with nuclear ARNT, and then associates with the unli-
ganded ERα or ERβ. The resulting complex recruits the co-
activator p300 to the promoter of the E2-responsive genes
leading to an E2-independent activation of the genes [41].
ERα or ERβ can also interact with the ARNT via their lig-
and-binding domains and activate the target genes. This
kind of interaction is E2-dependent and involves physical
interaction of the ERs with C-terminal trans-activation
domain of ARNT [42].
Conclusions
TCDD and other AH receptor ligands are capable to dis-
rupt E2-induced expression of the VTG gene. The negative
effect of TCDD on the expression of VTG gene is accompa-
nied by a reduction in ERα levels. Our results provide evi-
dence that this effect is mediated through a direct
interference with the auto-regulatory transcriptional loop
of ERα. Additionally, E2 does not interfere with TCDD
induced CYP1A gene expression, suggesting that cross-talk
between the ERα- and AHR-signalling pathways is
unidirectional.
Methods
Chemicals
Collagenase, 17β-estradiol, and testosterone were pur-
chased from Sigma (USA). 2,3,7,8-tetrachloro-dibenzo-p-
dioxin was purchased from Cambridge Isotope Laborato-
ries, Inc. (UK).
Preparation and culture of hepatocytes
Juvenile Atlantic salmon (Salmo salar), with approxi-
mately 500–700 g in weight, were kept in running seawa-
ter at a constant temperature of 12°C, at the Industrial
Laboratory (ILAB), HIB, Bergen, Norway. Hepatocytes
were isolated by a two-step perfusion described by Berry
and Friend [43], and modified by Andersson et al. [44].
Briefly, the liver was first perfused in situ with a calcium-
free solution containing NaCl (7.14 g/l); KCl (0.36 g/l),
MgSO4 (0.15 g/l); Na2 HPO4 (1.6 g/l); NaH2PO4 (0.4 g/l);
NaHCO3 (0.31 g/l) and EGTA (20 mg/l), at approximately
20°C. The liver was then perfused for about 10 min with
the same buffer, but with calcium (0.22 g/l) instead of
EGTA, and with collagenase A (EC 3.4.24.3, Sigma) (80
mg/150 ml). The cell suspension was filtered through a
150 µm nylon monofilament filter and centrifuged at 50
g for 5 min. Cells were washed with serum-free medium
three times and finally resuspended in the complete
medium. Viability of the cells was determined by Trypan
blue exclusion. The cells were plated on 35 mm Primaria
plates (Becto Dickinson Labware, USA) at a density of
about 5 × 106 per plate, in Minimum Essential Medium
with Earle's salts (EMEM), without phenol red (Gibco,
Invitrogen Corp. USA), and containing 2.5% (v/v) foetal
bovine serum, glutamine (0.3 g/l medium) and 1% (v/v)
antibiotic mixture (Penicillin, Streptomycin, Amphoter-
icin B). The cells were kept at 12°C in a humid
atmosphere containing 5% CO2 and 95% air. The cells
were kept in culture for, at least, 48 hours prior to treat-
ment with chemicals. The viability of the cells after each
treatment was always over 90%, as determined by the
Trypan blue exclusion assay.
RNA purification, Northern and slot blot analysis
Total cellular RNA was isolated using Trizol reagent,
according to the manufacturer's protocol (Invitrogen). For
Northern blot analysis, the samples were separated on a
1% formaldehyde-containing agarose gel, and transferred
to a nylon membrane by vacuum blotting. The RNA sam-
ples were immobilized on the membranes by UV-cross-
linking. The membranes were prehybridized at 42°C, for
about 12 hrs, in prehybridization solution containing
50% formamide, 5 X Denhardt's solution, 6 X SSPE
(1xSSPE equals 0.15 M NaCl, 10 mM sodium dihydro-
phosphate and 5 mM EDTA pH 7.2), 0.5% SDS, and 100
µg denatured herring sperm DNA, and hybridized with
the respective probe at 42°C for about 12 hrs in the same
hybridization solution. The membranes were washed 2
times (20 min/wash) in 1X SSPE/0.1% SDS at 42°C and
2 times (15 min/wash) at high stringency in 2 X SSPE/
0.1% SDS at 55°C. For slot blot analysis, total RNA was
applied to a nylon membrane using a slot blot apparatus,
immobilized, hybridized and washed by the same condi-
tions as described for Northern blot membranes.
Probes and labelling
The ERα probe was prepared by PCR amplification of the
hinge region of the ERα cDNA (accession number
X89959) obtained from Dr S.A. Rogers, School of Molec-
ular and Medical Biosciences, University of Wales, UK.
The primers used for amplification were ELaA (5'-AGG-
CAC-TTT-GTT-CTT-ACA-TTT-3') and ELaS (5'-TGG-TGC-
CTT-CTC-CTT-CTG-TT-3'). The PCR reaction was run
using AmpliTaq (Applied Biosystems) by the following
conditions: 1 cycle at 94°C for 5 min, 30 cycles at 94°C/
30 sec, 55°C/30 sec, 72°C/45 sec., 1 cycle at 72°C for 7
min. The VTG probe was derived from a VTG cDNA iso-
lated in our laboratory (Yadetie F., Goksøyr A. and Male
R., unpublished). The CYP1A1 probe was a NheIComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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restriction fragment from the plasmid pSG-15 containing
2553 base pairs of the rainbow trout CYP1A1 (accession
number M21310). The plasmid was a gift from Dr. D.W.
Nebert, Laboratory of Developmental Pharmacology,
NICHD; Bethesda, MD, USA. The β-actin probe was pre-
pared by PCR amplification of a region spanning nucle-
otides 225–724 of the Atlantic salmon β-actin cDNA
(accession number AF012125). The primers used for
amplification were ActinF (5'-CGT-CAC-CAA-CTG-GGA-
CGA-CA-3') and ActinR (5'-GCT-CGT-AGC-TCT-TCT-
CCA-G-3'). The PCR conditions were as described for
preparation of ERα probe. All probes were labelled by ran-
dom priming method using [α-32P]dCTP (3000 Ci/
mmol)(Amersham) according to Ausubel et al. [45]. The
images were scanned using Phosphoimager FLA-2000
(Fuji Photo Film CO. Ltd, Japan). Radioactivity was quan-
tified using Phosphoimager FLA-2000 as photo stimu-
lated luminescence (PSL).
Nuclear run-off transcription assay
Preparation of the active nuclei and performance of the
run-off transcription assay was performed following an
established protocol [45], with some modifications.
Preparation of the active nuclei
The cells were treated with E2, TCDD or a combination of
these chemicals for 8 hrs. The medium was removed and
the cells were washed two times with 2 ml of ice-cold
phosphate-buffered saline (PBS). The cells were gently
dislodged from the plastic surface by scraping with a rub-
ber policeman. The cells were collected by centrifugation
at 500 g for 5 min, at 4°C, and lysed using 1% Nonidet-
40 buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM
MgCl2,  1% V/V NP-40). The nuclei were isolated by
centrifugation at 2500 rpm in an Eppendorf centrifuge
and resuspended in 100 µl of glycerol storage buffer (50
mM Tris-HCl pH 8.3, 40% glycerol, 5 mM MgCl2, 0.1 mM
EDTA) by gently vortexing. The prepared nuclei were
immediately frozen and kept at -80°C.
Binding of plasmid DNA to nylon membrane
200 ng of each the respective plasmid DNA was linearized
with appropriate restriction enzyme, and denatured by
adding 1 M NaOH to a final concentration 0.1 M and by
incubation at room temperature, for 30 min. 10 X vol of
6 X SSC (1 X SSC contains 0.15 M NaCl and 0.015 M triso-
dium citrate pH 7.0) per sample was added and the plas-
mid DNA was spotted onto the membrane using a slot
blot apparatus (Schleicher & Schuell, Germany).
In vitro transcription assay
An aliquot of 100 µl of frozen nuclei was thawed at room
temperature and mixed with 100 µl of freshly prepared 2
X reaction buffer containing nucleotides (10 mM Tris-
HCl, pH 8.0, 5 mM MgCl2, 300 mM KCl, 5 mM dithioth-
reitol, and 0.5 nM of GTP, CTP, ATP and [α-32P]UTP (800
µCi/mmol)) and incubated for 30 min at 30°C.
Following in vitro transcription 1 X vol. of Trizol reagent
was added and the total RNA was isolated following the
instructions of the manufacturer. The yield of labelled
RNA was determined using a scintillation counter. The
membranes were hybridized to 1 × 106 cpm labelled RNA.
Prehybridization, hybridization and wash of the mem-
branes were performed by the same conditions as
described for Northern blot membranes.
Electrophoretic mobility shift assay (EMSA)
Preparation of nuclear extracts
The nuclear extracts were prepared by a previously
described protocol [46], with some modifications. A tri-
plet of cells cultured on 35 mm dishes was used in each
assay. After exposure of the cultured cells to the appropri-
ate chemicals the dishes were washed two times with ice-
cold PBS and the cells were harvested by trypsinization,
collected in 15-ml Falcon tubes by centrifuge at 500 g at
4°C, for 5 min, and washed 3 X with ice-cold PBS. After
the final wash, the cells were resuspended in 5 ml of
homogenization buffer (10 mM HEPES, pH 7.6, 10 mM
KCl, 1.5 mM MgCl2, 0.5 mM DTT) and incubated on ice
for 10 min. The cell suspensions were transferred to a pre-
cooled 7 ml tissue homogenizer and homogenized by 10
strokes. The homogenized cell suspensions were centri-
fuged at 500 g for 5 min. The pellet (enriched nuclei) was
resuspended in 3 ml of S1 solution (0.25 M sucrose, 10
mM MgCl2). The resuspended pellet was carefully layered
over 3 ml of S2 solution (0.35 M sucrose, 0.5 mM MgCl2)
and centrifuged at 4000 g, for 5 min, at 4°C. This step
resulted in a cleaner preparation of the nuclei. The nuclear
pellet was resuspended in 50 µl of nuclear lysis buffer (10
mM HEPES, pH 7.6, 100 mM KCl, 0.1 mM EDTA pH 8.0,
3 mM MgCl2, 10% glycerol and 1% NP-40 including a
protease inhibitor cocktail, 1 mM phenylmethylsulfonyl
fluoride (PMSF), pepstatin A, leupeptin, antipain, and
aprotinin) and transferred to an Eppendorf tube. The
resuspended pellet was incubated, on ice, for 10 min and
then centrifuged at 13000 rpm (12000 g), at 4°C, for 10
min. The supernatant was dialyzed against 1000 X volume
of the same buffer without NP-40, for 30 min, using a
Slide-A-Lyzer MINI dialysis unit (Pierce, USA) at 4°C. The
protein concentration in the samples were determined by
the method of Bradford [47] and the extracts were kept at
-80°C until use.
Performance of the EMSA
The complementary oligonucleotides (Medprobe, Oslo,
Norway) were mixed and annealed by incubation at
100°C, for 10 min, and slowly cooling to the room tem-
perature (for 1 hr). The probes used were a 3'-end biotin-
labelled DNA duplex of the sequence 5'-CATTCTGTTT-
GCTGTGTCATGTTGACCTGCTCTAGA-3', containing aComparative Hepatology 2004, 3 http://www.comparative-hepatology.com/content/3/1/2
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putative ERE derived from the proximal promoter region
of the Atlantic salmon ERα gene (Hanne Ravneberg and
Rune Male, unpublished), or a radioactive labelled ERE
oligo (ERE-sense oligo: 5'-CGGGGATCCTAGTAGGT-
CACAGTGACCTCATGGATCC-3', ERE-antisense oligo: 5'-
GGGGATCCATGAGGTCAGTGTGACCTACTAGGATCC-
3'). The radioactive probe was labelled by end-filling reac-
tion using DNA polymerase (Klenow fragment), and [α-
32P]dCTP (3000 Ci/mmol) according to the standard pro-
tocols [45]. The Oct probe was composed of a sense oligo-
nucleotide Oct-1: 5'-
CGGGGATCCTGATCCATGCAAATCGACGACT-3' and
antisense oligonucleotide Oct-1: 5'-GGGGATC-
CAGTCGTCGATTTGCATGGATCAG-3'. The binding reac-
tion with the biotinylated probe was performed according
to the instructions of the manufacturer, using the Light-
Shift Chemiluminescent EMSA kit (Pierce) and 1 µg of
nuclear extracts per reaction. The DNA-protein complexes
were electrophoresed through a 6% native polyacryla-
mide gel, and transferred to a nylon membrane electro-
phoretically. The samples were fixed to the membrane by
UV-cross-linking. The chemiluminescent detection was
performed as described by the manufacturer. The mem-
branes were exposed to an enhanced chemiluminescence
film (Kodak), for 5 seconds, before developing or scanned
using Phosphoimager FLA-2000 (Fuji Photo Film CO.
Ltd, Japan). Alternatively, 3 µl of nuclear extract was
mixed with 1 µg poly (dI-dC) in binding buffer (10 mM
Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM EDTA
and 4% glycerol), and incubated at room temperature for
15 min. The radio-labelled probe was subsequently added
to the mixture, and the binding reaction was further incu-
bated, at room temperature, for an additional 20 min
period, before fractionation by electrophoresis. The gels
were subsequently dried and exposed to phosphoimager
plates, overnight, before scanning.
Statistical analysis
Statistical analysis was performed by one-way ANOVA (n
= 3 in each group, unless otherwise indicated) using JMP
(version 5.0), SAS Institute Inc., USA. Data were tested for
normal distribution (Shapiro-Wilk W test) and for homo-
geneity of variance. Sets with homogeneous variances
were analysed by Dunnett's test to determine which
means were significantly different from a reference group
(P < 0.05).
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